Ultrasound Guided Port-A-Cath Isertion in Cancer Patients
- Conditions
- Cancer
- Interventions
- Device: Port-A-Cath
- Registration Number
- NCT04103021
- Lead Sponsor
- Omar Mokhtar Hussein
- Brief Summary
Port-A-Cath is a totally implanted central venous access system and one of the most frequently used systems for administration of chemotherapies in oncological patients .
The currently used techniques for placement of totally implantable venous access devices involve the open insertion by cut down technique, or percutaneous puncture of the central vein either by anatomical landmarks or image guided approach by using ultrasound guidance which is increasingly being preferred over the traditional anatomical landmark due to its low complication rate and high technical success rate; as this technique enables the direct visualization of needle entrance and advancement into the target vein
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
- cancer patients
- Indicated for receiving long term chemotherapy
- Accepted coagulation profile.
- Severe uncorrectable coagulopathy.
- Prior incidence of central vein thrombosis.
- Patients with active infection.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Port-a-cath Port-A-Cath Ultrasound guided Port-a-cath insertion
- Primary Outcome Measures
Name Time Method Early complications 24 hours Early complications associated with Ultrasound guided Port-a-cath insertion periprocedural and within 24 hours
- Secondary Outcome Measures
Name Time Method Late complications Up to 100 months complications associated with Ultrasound guided Port-a-cath insertion after 24 hours